Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Implantable Cardioverter Defibrillators (ICD) Pipeline Market Report Overview

An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm. ICDs contain three main components: a pulse generator, electrodes, and leads. However, the devices can also be leadless. The ICD pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Europe

·       Israel

·       Japan

·       South Korea

Key Categories ·       Single Chamber Implantable Cardioverter Defibrillators (ICD)

·       Subcutaneous Implantable Cardioverter Defibrillators (ICD)

Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       BOPA

·       NIFDS

Leading Companies ·       Advanced BioInformatics GmbH

·       AIS Inc.

·       Arrhythmia Dynamics LLC

·       AtaCor Medical Inc

·       Boston Scientific Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

ICD Pipeline Market Segmentation by Categories

The key categories in the ICD pipeline market are Single Chamber Implantable Cardioverter Defibrillators (ICD) and Subcutaneous Implantable Cardioverter Defibrillators (ICD). As of October 2024, Single Chamber Implantable Cardioverter Defibrillators (ICD) had the highest number of pipeline products.

ICD Pipeline Market Analysis by Categories, 2024 (%)

ICD Pipeline Market Analysis by Categories, 2024 (%)

Buy the Full Report for More Category Insights into the ICD Pipeline Market

Download a Free Report Sample

ICD Pipeline Market Segmentation by Territories

A few of the key territories associated with the ICD pipeline market are Europe, the United States, Israel, Japan, and South Korea among others. As of October 2024, the US had the highest number of ICD pipeline products.

ICD Pipeline Market Analysis by Territories, 2024 (%)

ICD Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the ICD Pipeline Market

Download a Free Report Sample

ICD Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the ICD pipeline products market are CE, NMPA, MDA, HSA, and 510(k). As of October 2024, PMA was the most followed pathway for pipeline products in the ICD market.

ICD Pipeline Market Analysis by Regulatory Paths, 2024 (%)

ICD Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the ICD Pipeline Market

Download a Free Report Sample

ICD Pipeline Market – Competitive Landscape

A few of the key companies associated with the ICD pipeline market are Advanced BioInformatics GmbH, AIS Inc., Arrhythmia Dynamics LLC, AtaCor Medical Inc, and Boston Scientific Corp.

Arrhythmia Dynamics LLC: Arrhythmia Dynamics LLC (Arrhythmia Dynamics) focuses on a smart defibrillator algorithm for the treatment of cardiac arrhythmias. The company is headquartered in Madison, Connecticut, the US.

AtaCor Medical Inc: AtaCor Medical Inc, is a medical device company that designs innovative solutions to deliver temporary, interim, and permanent cardiac pacing. The company is headquartered in the United States.

ICD Pipeline Market Analysis by Companies, As of October 2024
ICD Pipeline Market Analysis by Companies, As of October 2024Buy the Full Report for More Company Insights into the ICD Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

ICD Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe
  • Israel
  • Japan
  • South Korea

ICD Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • NMPA
  • BOPA
  • NIFDS

ICD Pipeline Market Categories Outlook (2024)

  • Single Chamber Implantable Cardioverter Defibrillators (ICD)
  • Subcutaneous Implantable Cardioverter Defibrillators (ICD)

Scope

The report provides:

  • Extensive coverage of the ICD under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of ICD and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of ICD under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Advanced BioInformatics GmbH
AIS Inc.
Arrhythmia Dynamics LLC
AtaCor Medical Inc
Boston Scientific Corp
CardiaLen, Inc.
Coridea, LLC
Endomimetics LLC
Impulse Dynamics Germany GmbH
InnerPulse Inc (Inactive)
Johns Hopkins University
Kenergy Inc.
Massachusetts General Hospital
Max Planck Institute for Dynamics and Self-Organization
Medicool Technologies Inc
Medtronic Inc
Medtronic Plc
MicroPort CRM SA
MicroPort Scientific Corp
Smartwave Medical Ltd (Inactive)
University of Chicago

Table of Contents

  • 1 Table of Contents
  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction

    • 2.1 Implantable Cardioverter Defibrillators (ICD) Overview

  • 3 Products under Development

    • 3.1 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development
    • 3.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment
    • 3.3 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory
    • 3.4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path
    • 3.5 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date
    • 3.6 Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials

  • 4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products under Development by Companies

    • 4.1 Implantable Cardioverter Defibrillators (ICD) Companies – Pipeline Products by Stage of Development
    • 4.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development

  • 5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview

    • 5.1 Advanced BioInformatics GmbH Company Overview

      • 5.1.1 Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 AIS Inc. Company Overview

      • 5.2.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Arrhythmia Dynamics LLC Company Overview

      • 5.3.1 Arrhythmia Dynamics LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 AtaCor Medical Inc Company Overview

      • 5.4.1 AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Boston Scientific Corp Company Overview

      • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 CardiaLen, Inc. Company Overview

      • 5.6.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Coridea, LLC Company Overview

      • 5.7.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Endomimetics LLC Company Overview

      • 5.8.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Impulse Dynamics Germany GmbH Company Overview

      • 5.9.1 Impulse Dynamics Germany GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 InnerPulse Inc (Inactive) Company Overview

      • 5.10.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Johns Hopkins University Company Overview

      • 5.11.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Kenergy Inc. Company Overview

      • 5.12.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Massachusetts General Hospital Company Overview

      • 5.13.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 Max Planck Institute for Dynamics and Self-Organization Company Overview

      • 5.14.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Medicool Technologies Inc Company Overview

      • 5.15.1 Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Medtronic Inc Company Overview

      • 5.16.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Medtronic Plc Company Overview

      • 5.17.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 MicroPort CRM SA Company Overview

      • 5.18.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 MicroPort Scientific Corp Company Overview

      • 5.19.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Smartwave Medical Ltd (Inactive) Company Overview

      • 5.20.1 Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 University of Chicago Company Overview

      • 5.21.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments

    • 6.1 Oct 04, 2024: CONMED Corp Announces Preliminary Third Quarter Financial Information
    • 6.2 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
    • 6.3 Sep 02, 2024: Medtronic EV ICD Global Pivotal Trial Final Results Demonstrate High ATP Success and Effective Defibrillation: ESC Congress 2024
    • 6.4 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
    • 6.5 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
    • 6.6 Aug 02, 2024: Nihon Kohden Announces Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2025
    • 6.7 Jul 08, 2024: CONMED to Announce Second Quarter 2024 Financial Results on July 31, 2024
    • 6.8 Jun 13, 2024: Medtronic Confirms Global Layoffs
    • 6.9 May 13, 2024: Impulse Dynamics Surpasses 10,000 Patients Benefiting From CCM Therapy for Heart Failure
    • 6.10 Apr 08, 2024: First-in-human study demonstrates reduction of hard-to-reach ventricular tachycardias
    • 6.11 Apr 08, 2024: Preventive ablation of ventricular tachycardia avoids shocks and hospitalisation
    • 6.12 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
    • 6.13 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
    • 6.14 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
    • 6.15 Feb 20, 2024: Philips Delivers Strong ESG Performance in 2023
    • 6.16 Feb 18, 2024: MicroPort CRM AAnnounces the Launch of GALI SonR CRT-D and NAVIGO 4LV left ventricular pacing leads in Japan
    • 6.17 Feb 16, 2024: St. Elizabeth Healthcare First in Kentucky to Implant New Device To Treat Abnormal Heart Rhythm
    • 6.18 Jan 29, 2024: BIOTRONIK’s DX Technology Reaches Significant Milestone: 100,000 DX Devices Implanted
    • 6.19 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • 6.20 Nov 02, 2023: Medtronic Obtains Pre-Market Approval (PMA) for Aurora EV-ICD MRI SureScan System
    • 6.21 Oct 31, 2023: CONMED Corp. to Participate in Fireside Chats at Two Investor Conferences on November 14-15
    • 6.22 Oct 24, 2023: FDA approves Medtronic’s Aurora EV-ICD system

  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date

Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials

Implantable Cardioverter Defibrillators (ICD) Companies – Pipeline Products by Stage of Development

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development

Advanced BioInformatics GmbH Pipeline Products & Ongoing Clinical Trials Overview

Cardiac Rhythm Management Device – Product Status

Cardiac Rhythm Management Device – Product Description

AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview

Guardian – Product Status

Guardian – Product Description

Arrhythmia Dynamics LLC Pipeline Products & Ongoing Clinical Trials Overview

IntelliSync ICD Control Algorithm – Product Status

IntelliSync ICD Control Algorithm – Product Description

AtaCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

Atala lead – Product Status

Atala lead – Product Description

Third Generation EV-ICD Lead – Product Status

Third Generation EV-ICD Lead – Product Description

AtaCor Medical Inc – Ongoing Clinical Trials Overview

Atala lead – Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

S-ICD System 1.5 – Product Status

S-ICD System 1.5 – Product Description

Vitality Nxt Defibrillator – Product Status

Vitality Nxt Defibrillator – Product Description

CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview

MultiPulse Therapy Device – Product Status

MultiPulse Therapy Device – Product Description

CardiaLen, Inc. – Ongoing Clinical Trials Overview

MultiPulse Therapy Device – Study Evaluating the Safety and Efficacy of MultiPulse Therapy in an Acute Clinical Setting

Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview

Table-Top PaDe System – Product Status

Table-Top PaDe System – Product Description

Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview

Automated Implantable Cardioverter Defibrillator Lead – Product Status

Automated Implantable Cardioverter Defibrillator Lead – Product Description

Impulse Dynamics Germany GmbH Pipeline Products & Ongoing Clinical Trials Overview

Optimizer Integra CCM-D System – Product Status

Optimizer Integra CCM-D System – Product Description

Impulse Dynamics Germany GmbH – Ongoing Clinical Trials Overview

Optimizer Integra CCM-D System – Assessment of the Safety and Efficacy of a Combined Cardiac Contractility Modulation and Implantable Cardioverter Defibrillator Device for Subjects with Heart Failure and Reduced Ejection Fraction

InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

PICD – Product Status

PICD – Product Description

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview

Cardiac Sock Electrode And Implantable Defibrillator System – Product Status

Cardiac Sock Electrode And Implantable Defibrillator System – Product Description

Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview

Unconditional MRI Compatible Implantable Defibrillator – Product Status

Unconditional MRI Compatible Implantable Defibrillator – Product Description

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview

Implantable Cardioverter Defibrillator – Ventricular Arrhythmias – Product Status

Implantable Cardioverter Defibrillator – Ventricular Arrhythmias – Product Description

Vagal Stimulation ICD Device – Product Status

Vagal Stimulation ICD Device – Product Description

Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview

Implantable Defibrillator – Product Status

Implantable Defibrillator – Product Description

Medicool Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Implantable Defibrillator – Product Status

Implantable Defibrillator – Product Description

Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview

LUMINA EV-ICD – Product Status

LUMINA EV-ICD – Product Description

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

Chronicle ICD – Product Status

Chronicle ICD – Product Description

MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview

Navigo 4LV PILOT – Product Status

Navigo 4LV PILOT – Product Description

Subcutaneous ICD – Product Status

Subcutaneous ICD – Product Description

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

Space HP ICD – Product Status

Space HP ICD – Product Description

Smartwave Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Fully Automatic Implantable Atrial Defibrillator – Product Status

Fully Automatic Implantable Atrial Defibrillator – Product Description

University of Chicago Pipeline Products & Ongoing Clinical Trials Overview

Implantable Cardioverter Defibrillator – Product Status

Implantable Cardioverter Defibrillator – Product Description

Glossary

Figures

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path

Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date

Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials

Frequently asked questions

Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.